Quick verdict
Found is the better pick for most patients on overall scoring. Found has the broadest medication catalog of any program here, including off-label tirzepatide and orforglipron access through their Foundayo program. The 6-month non-refundable subscription is the catch.
That said, Calibrate wins on specific dimensions. Calibrate is a coaching and insurance-navigation program whose value proposition has weakened as direct-to-consumer pricing from Lilly and Novo undercut the 'we'll handle insurance for you' pitch. Cut its fee from $299 to $199 in 2026.
Side-by-side
| Found | Calibrate | |
|---|---|---|
| Starts from | $99/mo (+ med separate) | $199/mo (+ med separate) |
| Lock-in | 6-month lock-in | 3-month minimum |
| Time to prescription | 5 days | 14 days |
| Consultation type | Asynchronous | Synchronous |
| Affiliate network | Impact | Impact |
Score by dimension
Five dimensions, ten points each. The winner of each dimension is highlighted.
| Found | Calibrate | |
|---|---|---|
| Pricing transparency | 6/10 | 5/10 |
| Cancellation terms | 3/10 | 6/10 |
| Onboarding experience | 8/10 | 4/10 |
| Medication options | 9/10 | 7/10 |
| Member outcomes | 5/10 | 3/10 |
When to choose Found
Patients whose obesity medicine clinician has flagged a non-standard medication path (multiple drug classes, off-label combinations, or 503A-compounded options that other programs have exited).
When to choose Calibrate
Patients who specifically want behavioral coaching and have insurance that covers branded GLP-1s. Calibrate's clinicians and coaches handle prior authorization paperwork well.
FAQ
Is Found cheaper than Calibrate?
Can I switch from Found to Calibrate mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart →